Detalles de la búsqueda
1.
Sickle cell disease in Germany: Results from a national registry.
Pediatr Blood Cancer
; 67(4): e28130, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31867835
2.
Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial.
BMC Cancer
; 15: 392, 2015 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25957784
3.
Some Issues of Sample Size Calculation for Time-to-Event Endpoints Using the Freedman and Schoenfeld Formulas.
J Biopharm Stat
; 25(6): 1285-311, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25629760
4.
Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study.
BMC Cancer
; 10: 607, 2010 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-21054824
5.
Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.
BMC Cancer
; 10: 96, 2010 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-20226028
6.
An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2nd or higher line chemotherapy regarding clinical benefit - PANUSCO.
BMC Cancer
; 9: 412, 2009 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-19943918
7.
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma.
Neuro Oncol
; 21(1): 95-105, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30277538
8.
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia.
Clin Epigenetics
; 11(1): 188, 2019 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31823832
9.
Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.
Eur J Cancer
; 51(5): 569-76, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25694417
10.
Sample sizes for time-to-event endpoints: should you insure against chance variations in accrual?
Contemp Clin Trials
; 33(2): 456-8, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22094431
Resultados
1 -
10
de 10
1
Próxima >
>>